ImmunologybioRxiv
Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants
M. Ferrari, L. Mekkaoui, F. T. Ilca…·S. Onuoha
The paper characterizes a novel ACE2-based therapeutic that effectively neutralizes SARS-CoV-2 variants and demonstrates antibody-like properties and manufacturability.
DOI 10.1128/jvi.00685-21